Combination Activity of Standard Antituberculosis Drugs and Extracts of Medicinal Plants Commonly Used in Traditional Treatment of Tuberculosis in Uganda
Introduction: Resistance to antituberculosis drugs and adverse drug reactions remain the leading causes of tuberculosis therapeutic failure globally. Despite the increasing acceptance of medicinal plant use in combination with conventional antituberculosis drugs in treatment of tuberculosis (TB) in Uganda, there is paucity of knowledge on their combination effect. Aim: This research aimed to determine combination activity of standard antituberculosis drugs with extracts of Zanthoxylum leprieurii Guill. & Perr. and Rubia cordifolia L., the two common antituberculosis medicinal plants in Uganda, against pansensitive (H37Rv) and multi-drug resistant (MDR) Mycobacterium tuberculosis strains. Materials and Methods: Two reference MTB strains (H37Rv and MDR strain) were inoculated on Middlebrook 7H11 medium containing a combination of standard antituberculosis drugs and methanol extracts of Z. leprieurii and R. cordifolia at varying concentrations. The number of colonies on the plates was observed and counted weekly for up to 8 weeks. In vitro combination activity was determined using proportion method. Mean percentage inhibition was calculated for the reduction of number of colonies on drug-extract combination medium in relation to drug-extract-free control medium. Results: Drug-extract combinations showed good combination activity against Mycobacterium tuberculosis strains when compared with individual standard anti-TB drugs. This was more exhibited against MDR strain. There was however a reduction in percentage inhibition when extracts were combined with ethambutol and streptomycin against H37Rv strain. Conclusions:Zanthoxylum leprieurii and Rubia cordifolia in combination with standard anti-TB drugs exhibited increased in vitro activity against Mycobacterium tuberculosis, especially MDR-TB strain. This justifies the local use of these plants in traditional treatment of tuberculosis especially in resistant cases in Uganda.
References
[1]
WHO (2022) Global Tuberculosis Report 2022.
[2]
Hegeto, L.A., Caleffi-Ferracioli, K.R., Nakamura-Vasconcelos, S.S., Almeida, A.L.d., Baldin, V.P., Nakamura, C.V., et al. (2018) In Vitro Combinatory Activity of Piperine and Anti-Tuberculosis Drugs in Mycobacterium Tuberculosis. Tuberculosis, 111, 35-40. https://doi.org/10.1016/j.tube.2018.05.006
[3]
Garg, S., Kumar, R., Kunimoto, D. and Rayat, G.R. (2022) Anti-Mycobacterial Activity of Flavonoid and Pyrimidine Compounds. Molecules, 27, Article 6714. https://doi.org/10.3390/molecules27196714
[4]
Mpeirwe, M., Taremwa, I.M., Orikiriza, P., Ogwang, P.E., Ssesazi, D. and Bazira, J. (2023) Anti-mycobacterial Activity of Medicinal Plant Extracts Used in the Treatment of Tuberculosis by Traditional Medicine Practitioners in Uganda. Pharmacology & Pharmacy, 14, 33-42. https://doi.org/10.4236/pp.2023.142003
[5]
Pontali, E., Raviglione, M.C. and Migliori, G.B. (2019) Regimens to Treat Multidrug-Resistant Tuberculosis: Past, Present and Future Perspectives. European Respiratory Review, 28, Article ID: 190035. https://doi.org/10.1183/16000617.0035-2019
[6]
Logiel, A., Jørs, E., Akugizibwe, P. and Ahnfeldt-Mollerup, P. (2021) Prevalence and Socio-Economic Factors Affecting the Use of Traditional Medicine among Adults of Katikekile Subcounty, Moroto District, Uganda. African Health Sciences, 21, 1410-1417. https://doi.org/10.4314/ahs.v21i3.52
[7]
WHO (2002) WHO Traditional Medicine Strategy 2002-2005.
[8]
Bunalema, L., Obakiro, S., Tabuti, J.R.S. and Waako, P. (2014) Knowledge on Plants Used Traditionally in the Treatment of Tuberculosis in Uganda. Journal of Ethnopharmacology, 151, 999-1004. https://doi.org/10.1016/j.jep.2013.12.020
[9]
Tabuti, J.R.S., Kukunda, C.B. and Waako, P.J. (2010) Medicinal Plants Used by Traditional Medicine Practitioners in the Treatment of Tuberculosis and Related Ailments in Uganda. Journal of Ethnopharmacology, 127, 130-136. https://doi.org/10.1016/j.jep.2009.09.035
[10]
Obakiro, S.B., Kiprop, A., Kowino, I., Kigondu, E., Odero, M.P., Omara, T., et al. (2020) Ethnobotany, Ethnopharmacology, and Phytochemistry of Traditional Medicinal Plants Used in the Management of Symptoms of Tuberculosis in East Africa: A Systematic Review. Tropical Medicine and Health, 48, Article No. 68. https://doi.org/10.1186/s41182-020-00256-1
[11]
Oloya, B., Namukobe, J., Ssengooba, W., Afayoa, M. and Byamukama, R. (2022) Phytochemical Screening, Antimycobacterial Activity and Acute Toxicity of Crude Extracts of Selected Medicinal Plant Species Used Locally in the Treatment of Tuberculosis in Uganda. Tropical Medicine and Health, 50, Article No. 16. https://doi.org/10.1186/s41182-022-00406-7
[12]
Tuyiringire, N., Deyno, S., Weisheit, A., Tolo, C.U., Tusubira, D., Munyampundu, J., et al. (2020) Three Promising Antimycobacterial Medicinal Plants Reviewed as Potential Sources of Drug Hit Candidates against Multidrug-Resistant Tuberculosis. Tuberculosis, 124, Article ID: 101987. https://doi.org/10.1016/j.tube.2020.101987
[13]
Van Wyk, B.E., van Oudtshoorn, B. and Gericke, N. (1997) Medicinal Plants of South Africa. Briza.
[14]
de Lima Toccafondo Vieira, M. and Huang, S. (2012) Botanical-Drug Interactions: A Scientific Perspective. Planta Medica, 78, 1400-1415. https://doi.org/10.1055/s-0032-1315145
[15]
Butterweck, V. and Derendorf, H. (2012) Herb-Drug Interactions. Planta Medica, 78, 1399-1399. https://doi.org/10.1055/s-0032-1315285
[16]
Hübsch, Z., Van Zyl, R.L., Cock, I.E. and Van Vuuren, S.F. (2014) Interactive Antimicrobial and Toxicity Profiles of Conventional Antimicrobials with Southern African Medicinal Plants. South African Journal of Botany, 93, 185-197. https://doi.org/10.1016/j.sajb.2014.04.005
[17]
Nguta, J.M., Appiah-Opong, R., Nyarko, A.K., Yeboah-Manu, D., Addo, P.G.A., Otchere, I., et al. (2016) Antimycobacterial and Cytotoxic Activity of Selected Medicinal Plant Extracts. Journal of Ethnopharmacology, 182, 10-15. https://doi.org/10.1016/j.jep.2016.02.010
[18]
Gemechu, A., Giday, M., Worku, A. and Ameni, G. (2013) In Vitro Anti-Mycobacterial Activity of Selected Medicinal Plants against Mycobacterium Tuberculosis and Mycobacterium Bovis Strains. BMC Complementary and Alternative Medicine, 13, Article No. 291. https://doi.org/10.1186/1472-6882-13-291
[19]
Swami, H.S., Singh, K., Gennaro, L. and Dutt, R. (2008) Extraction Technologies for Medicinal and Aromatic Plants. Trieste: United Nations Industrial Development Organization and the International Centre for Science and High Technology.
[20]
Pitaloka, D.A.E. and Sukandar, E.Y. (2018) Synergistic Study on n-Hexane Extract of Anredera cordifolia (Ten.) v Steenis (Binahong) Leaves Combined with Antituberculosis Drugs against Drug-Sensitive and Drug-Resistant of Mycobacterium Tuberculosis. Journal of Applied Pharmaceutical Science, 8, 134-138.
[21]
Fauziyah, P.N., Sukandar, E.Y. and Ayuningtyas, D.K. (2017) Combination Effect of Antituberculosis Drugs and Ethanolic Extract of Selected Medicinal Plants against Multi-Drug Resistant Mycobacterium Tuberculosis Isolates. Scientia Pharmaceutica, 85, Article 14. https://doi.org/10.3390/scipharm85010014
[22]
WHO (2018) Technical Manual for Drug Susceptibility Testing of Medicines Used in the Treatment of Tuberculosis.
[23]
Chinsembu, K.C. (2016) Tuberculosis and Nature’s Pharmacy of Putative Anti-Tuberculosis Agents. Acta Tropica, 153, 46-56. https://doi.org/10.1016/j.actatropica.2015.10.004
[24]
Koul, A., Arnoult, E., Lounis, N., Guillemont, J. and Andries, K. (2011) The Challenge of New Drug Discovery for Tuberculosis. Nature, 469, 483-490. https://doi.org/10.1038/nature09657
[25]
Bunalema, L., Fotso, G.W., Waako, P., Tabuti, J. and Yeboah, S.O. (2017) Potential of Zanthoxylum Leprieurii as a Source of Active Compounds against Drug Resistant Mycobacterium Tuberculosis. BMC Complementary and Alternative Medicine, 17, Article No. 89. https://doi.org/10.1186/s12906-017-1602-x
[26]
Belknap, R. and Haas, M. (2018) Updates in the Treatment of Active and Latent Tuberculosis. Seminars in Respiratory and Critical Care Medicine, 39, 297-309. https://doi.org/10.1055/s-0038-1660863
[27]
Makgatho, M., Nxumalo, W., Ndaba, E., Masilo, C., Tsindane, F. and Sedibane, M. (2017) Evaluation of the Anti-Mycobacterial, Anti-Oxidative and Anti-Proliferative Activities of Rubia Cordifolia Ethanolic Leaf Extract Sub-Fractions in Human Lymphocytes and Neutrophils. African Journal of Traditional, Complementary and Alternative Medicines, 14, 181-187. https://doi.org/10.21010/ajtcam.v14i5.21
